Journal article · 2026 · Open access
Domain-alteration chimeras rewire oncogenic complexes in prostate cancer
Nature · Published 11 November 2026 · DOI 10.1038/s41586-026-11262-4
In brief
“Domain-alteration chimeras rewire oncogenic complexes in prostate cancer” is a 2026 journal article by Jie Luo and 28 co-authors, published in Nature. OpenAlex counts 2 citations as of 18 November 2026, which puts it in the top 5% of works published in 2026 by citations. It is open access under a CC BY licence: the full text is free to read at Nature.
- Citations
- 2
- Most cited in
- 2026 (2)
- Field-weighted impact
- 3.75
- References
- 107
- Authors
- 29
Abstract
Transcriptional addiction to the androgen receptor (AR) underlies metastatic castration-resistant prostate cancer 1 , in which AR maintains oncogenic programs through domain-specific interactions with the acetyltransferases p300 and CBP (collectively p300/CBP) 2 . Here we describe a novel therapeutic modality, domain-alteration chimeras (DALTACs), that rewire endogenous protein complexes by enforcing non-native domain–domain interactions. Our first-in-class AR–p300/CBP DALTAC-1 induces synthetic proximity between the ligand-binding domain of AR and the bromodomain of p300/CBP, misconfiguring their native interface and locking the complex in a non-productive state. DALTAC-1 triggers a ‘super-inhibitory’ effect, suppressing AR-driven transcription and proliferation more potently than combined AR and p300/CBP inhibition. Mechanistically, DALTAC-1 reprograms p300/CBP substrate engagement, abolishing the histone mark H2B N-terminal acetylation and inducing neomorphic acetylation of AR and coactivators, ultimately collapsing the AR neo-enhanceosome. Chromatin profiling revealed redistribution of AR and p300/CBP towards palindromic androgen response elements, accompanied by disruption of cofactor and transcriptional machinery recruitment at oncogenic AR and ERG neo-enhancers. DALTAC-1 exhibits exquisite lineage selectivity, displaying potent activity in AR–p300/CBP dual-dependent cells and sparing AR-negative cells. In multiple in vivo models, DALTAC-1 induces deep and durable tumour regressions. Together, these findings establish DALTACs as a broadly applicable strategy to rewire disease-defining complexes through domain-topology alteration, expanding induced-proximity therapies, and the precise lineage selectivity of DALTAC-1 supports its translational potential in AR-driven prostate cancer.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Luo, J., Yang, J., Tien, J. C.-Y., Wang, M., Das, S., Wang, X., Young, E., Tošović, J., Mannan, R., Xiang, W., Jiang, X., Cai, J., Liu, Y., Gu, K., Mahapatra, S., Li, S., Yin, Y., Eyunni, S., Todd, A. J., . . . Chinnaiyan, A. M. (2026). Domain-alteration chimeras rewire oncogenic complexes in prostate cancer. Nature. https://doi.org/10.1038/s41586-026-11262-4
MLA 9
Luo, Jie, et al. “Domain-alteration chimeras rewire oncogenic complexes in prostate cancer.” Nature, 2026. https://doi.org/10.1038/s41586-026-11262-4.
Chicago
Luo, Jie, Jianzhang Yang, Jean Ching-Yi Tien, Mi Wang, Sumit Das, Xiaoju Wang, Eleanor Young, et al. 2026. “Domain-alteration chimeras rewire oncogenic complexes in prostate cancer.” Nature. https://doi.org/10.1038/s41586-026-11262-4.
Harvard
Luo, J. et al. (2026) ‘Domain-alteration chimeras rewire oncogenic complexes in prostate cancer’, Nature. doi:10.1038/s41586-026-11262-4.
IEEE
J. Luo et al., “Domain-alteration chimeras rewire oncogenic complexes in prostate cancer,” Nature, 2026, doi: 10.1038/s41586-026-11262-4.
BibTeX
@article{luo2026domain,
title = {{Domain-alteration chimeras rewire oncogenic complexes in prostate cancer}},
author = {Luo, Jie and Yang, Jianzhang and Tien, Jean Ching-Yi and Wang, Mi and Das, Sumit and Wang, Xiaoju and Young, Eleanor and Tošović, Jelena and Mannan, Rahul and Xiang, Weiguo and Jiang, Xia and Cai, Jocelyn and Liu, Yihan and Gu, Kenneth and Mahapatra, Somnath and Li, Shiting and Yin, Yitong and Eyunni, Sanjana and Todd, Abigail J. and Jin, Shicheng and Cao, Xuhong and Su, Fengyun and Miner, Stephanie J. and Sudharshan, Ranga and Rao, Arvind and Parolia, Abhijit and Qiao, Yuanyuan and Wang, Shaomeng and Chinnaiyan, Arul M.},
journal = {Nature},
year = {2026},
doi = {10.1038/s41586-026-11262-4},
url = {https://doi.org/10.1038/s41586-026-11262-4}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- androgen receptor
- CBP/p300
- castration-resistant prostate cancer
- synthetic lethality
- induced proximity
- bromodomain
- ligand-binding domain
- ERG
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Luo, J., Yang, J., Tien, J. C.-Y., Wang, M., Das, S., Wang, X., Young, E., Tošović, J., Mannan, R., Xiang, W., Jiang, X., Cai, J., Liu, Y., Gu, K., Mahapatra, S., Li, S., Yin, Y., Eyunni, S., Todd, A. J., . . . Chinnaiyan, A. M. (2026). Domain-alteration chimeras rewire oncogenic complexes in prostate cancer. Nature. https://doi.org/10.1038/s41586-026-11262-4
How many times has this paper been cited?
2 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Nature: sign in and open the PDF from this page.
Who wrote this paper?
Jie Luo, Jianzhang Yang, Jean Ching-Yi Tien, Mi Wang, Sumit Das, Xiaoju Wang, Eleanor Young, Jelena Tošović, Rahul Mannan, Weiguo Xiang, Xia Jiang, Jocelyn Cai and 17 more.
What is the DOI of this paper?
10.1038/s41586-026-11262-4, permanently at https://doi.org/10.1038/s41586-026-11262-4. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.